In 2022, the size of the global tumor ablation market was estimated at USD 1,018.6 million. It is projected to experience a CAGR of 11.5% from 2023 to 2030. The market is expected to expand due to an increase in the elderly population and a rise in cancer or tumor cases. However, the growth of the market may be hampered by complications associated with tumor ablation therapy. The market is segmented based on treatment, application, and technology.
Definition: Tumor ablation refers to a less invasive surgical technique used for treating solid malignancies. The procedure involves the use of specialized probes that heat or freeze cancer cells without requiring major surgery. Imaging technologies such as computed tomography, ultrasound, or magnetic resonance imaging are used to guide and accurately position the needle probe into the tumor. This approach typically involves a small incision, usually less than 3 mm, through which the probe is introduced.
Market Drivers:
Ablation is a therapeutic procedure that injures liver cancer cells while leaving them in place. It is particularly beneficial for patients with small tumors or when surgery is not an option. Additionally, patients undergoing this type of therapy typically do not need to stay in the hospital, which has led to an increase in the adoption of ablation systems among the general population.
The rising incidence of various types of cancer, including colon cancer, lung cancer, breast carcinoma, and prostate cancer, is anticipated to drive the demand for ablation machinery for treating cancer in the liver, kidney, bones, and soft tissues. Cancer is a global healthcare challenge and a leading cause of mortality.
Ask Us to Get Your Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/1270
Market Opportunities:
The increasing awareness of ablation techniques using traditional therapies and surgery is expected to drive the growth of the global tumor ablation market and create favorable prospects for its expansion.
Additionally, the growing number of emerging markets and the approval of new products are generating numerous beneficial opportunities that will continue to drive growth in the tumor ablation market in the forecasted period.
Market Trends:
Globally, lung cancer is a leading cause of death, characterized by two main forms: small cell lung carcinoma and non-small cell lung carcinoma, which are distinguished by their microscopic appearance. Non-small cell lung carcinoma is more prevalent than small cell lung carcinoma. The increasing prevalence of lung cancer, driven by unhealthy habits and a surge in research and development efforts along with the approval of products, is propelling the market segment’s growth.
The growth of the segment is being propelled by increasing medical analysis of lung carcinoma and ablation therapy. Ethicon Inc. conducted a research survey in December 2021 to assess the effectiveness and safety of a new wave-certus microwave ablation method in Chinese patients with primary or secondary lung cancer. The survey is expected to be completed by December 2024.
Market Restraints:
Ablation therapy for solid organ cancer is increasingly being considered a feasible treatment option, but as the number of procedures increases, so does the potential for complications. The most common adverse effects of ablation include bleeding and damage to the target organ.
The side effects of these procedures are classified based on their associated risks and may impede market growth. Ablation strategies are classified by the Food and Drug Administration as Class II and III clinical devices, which require extensive monitoring and regulation.
Recent Developments
The US Food and Drug Administration granted Medtronic a breakthrough device designation for its Emprint ablation catheter kit in April 2021. This designation helps strengthen the company’s product portfolio.
The OsteoCool RF ablation system received approval from the Food and Drug Administration in February 2017 for providing palliative therapy to patients with metastatic bone cancers.
In August 2020, Ethicon, which is a division of Johnson & Johnson, was granted the breakthrough device designation by the Food and Drug Administration for their microwave machinery. This initiative proved beneficial for the company as it aided in enhancing its revenue generation.
Regional Insights
The global tumor ablation market is divided into different regions based on geography, including Africa, Latin America, Europe, the Middle East, North America, and Asia Pacific. Among these regions, North America has emerged as the dominant market for tumor ablation. This growth can be attributed to several factors, such as regulatory support for quality healthcare, strong purchasing power, the availability of reimbursement, and the increasing incidence of cancer in both the United States and Canada.
Europe’s significant contribution to the tumor ablation market can be attributed to the substantial public spending in its healthcare system, which has supported market growth. Moreover, the increase in the aging population and regulatory aid in managing cancer have also contributed to the substantial expansion of the market.
Global Tumor Ablation Market Categorization:
The global tumor ablation market report is categorized based on treatment, application, and technology.
The market is divided into radio frequency ablation, microwave ablation, and other technologies, with radio frequency ablation being a minimally invasive and nonsurgical procedure used to treat painful neck, sacroiliac joint pain, and back facet joints. This technology offers several benefits.
Microwave ablation is a technique that utilizes electromagnetic waves with a device operating at a minimum frequency of 900 MHz to destroy tumors. Compared to other machines, it offers several advantages in terms of its ability to efficiently eliminate cancer cells. These benefits include consistent high temperatures, the capacity to ablate large tumors, shorter ablation times, and reduced pain.
The market segmentation is based on the type of treatment, which includes surgical ablation and laparoscopic ablation. Among these, laparoscopic surgeries involve the insertion of a slender tube through a small incision in the abdomen and are commonly used to treat cancer in abdominal organs like the kidney and liver. This approach utilizes specialized tools to make small incisions, thereby reducing the recovery time.
The surgical ablation process, which is another type of software, is a minimally invasive treatment that uses ablation catheters or probes to deliver energy directly to the cancer site for therapy. Unlike medical eradication of tumors or infected cells, this therapy is intended for patients who have difficulty with medical eradication of cancer/carcinoma cells.
The market is categorized into kidney cancer and liver cancer, among others, based on their application. For kidney cancer, both microwave ablation and radiofrequency ablation treatments employ image guidance to direct the syringe from the skin to the cancerous area. Microwave ablation uses microwaves to generate a small area of heat in the syringe, which destroys and damages the tumor cells in the kidney. On the other hand, radiofrequency ablation creates a small area of heat by passing high-frequency electrical signals from the electrode in the syringe.
Ablation therapy is a treatment option for liver cancer that involves damaging the tumor without removing it surgically. It is typically recommended for patients with small cancers that cannot be removed through conventional clinical methods. However, when the size of the cancer exceeds 3 cm, ablation therapy is not recommended because it can also damage normal tissue.
Major Company Insights
The intense competition in the global tumor ablation market is the result of consistent advancements in technology as a result of ongoing research and development, and the efforts of value chain participants. Additionally, major industry players are implementing a range of business expansion strategies to extend their reach on both regional and global levels. Some of the leading companies in the global tumor ablation market are Boston Scientific Corporation, Medtronic, IceCure Medical, Johnson & Johnson Services Inc., H.S. Hospital Service SPA, EDAP TMS, AngioDynamics, and Theraclion.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/1270
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Tumor Ablation Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Tumor Ablation Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/1270
Explore More Related Insights:
- Drug Delivery Device Market
- Mammography Market
- Biosurgery Market
- Neurofeedback Systems Market
- Pressure Infusion Bags Market
- Surgical Drills Market
- Dental Amalgam Separator Market
- Dental Turbine Market
- Urology Device Market
- Sterilization Services Market
- Portable Medical Devices Market
- Medical Imaging Reagents Market
- Healthcare Chatbots Market
- Kirschner Wire Market
- Medical Equipment Rental Market
- Shigella Test Kit Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837